0000000001288064

AUTHOR

Meshkan Moghimi

showing 1 related works from this author

Treatment of cervicofacial actinomycosis: a report of 19 cases and review of literature

2013

Objectives: Actinomycosis is a chronic suppurative granulomatous infection caused by the Actinomyces genus. Orocervicofacial actinomycosis is the most common form of the disease, seen in up to 55% of cases. All forms of actinomycosis are treated with high doses of intravenous penicillin G over two to six weeks, followed by oral penicillin V. Large studies on cervicofacial actinomycosis are lacking. Therefore proper guidelines for treatment and treatment duration are difficult to establish. The aim of this study is to establish effective treatment and treatment duration for orocervicofacial actinomycosis. Study design: A Pubmed and Embase search was performed with the focus on treatment and …

medicine.medical_specialtymedicine.drug_classAntibioticsOdontologíaActinomycosis CervicofacialSDG 3 - Good Health and Well-beingClavulanic acidmedicineHumansCombined Modality TherapyGeneral DentistryRetrospective StudiesOral Medicine and Pathologybusiness.industryRetrospective cohort studyAmoxicillin:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCombined Modality TherapyCiencias de la saludDermatologyAnti-Bacterial AgentsSurgeryPenicillinOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASEtiology/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingResearch-ArticleSurgeryActinomycosisbusinessmedicine.drugMedicina Oral, Patologia Oral y Cirugia Bucal
researchProduct